{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:01:03Z","timestamp":1793815263602,"version":"4.6.1"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>JOURNAL\/nrgr\/04.03\/01300535-202603000-00041\/figure1\/v\/2026-04-22T011420Z\/r\/image-tiff<\/jats:p>\n                  <jats:p>\n                    Intrathecal administration of human umbilical cord mesenchymal stem cells may be a promising approach for the treatment of stroke, but its safety, effectiveness, and mechanism remain to be elucidated. In this study, good manufacturing practice\u2013grade human umbilical cord mesenchymal stem cells (5 \u00d7 10\n                    <jats:sup>5<\/jats:sup>\n                    and 1 \u00d7 10\n                    <jats:sup>6<\/jats:sup>\n                    cells) and saline were administered by cerebellomedullary cistern injection 72 hours after stroke induced by middle cerebral artery occlusion in rats. The results showed (1) no significant difference in mortality or general conditions among the three groups. There was no abnormal differentiation or tumor formation in various organs of rats in any group. (2) Compared with saline-treated animals, those treated with human umbilical cord mesenchymal stem cells showed significant functional recovery and reduced infarct volume, with no significant differences between different human umbilical cord mesenchymal stem cell doses. (3) Human umbilical cord mesenchymal stem cells were found in the ischemic brain after 14 and 28 days of follow-up, and the number of positive cells significantly decreased over time. (4) Neuronal nuclei expression in the human umbilical cord mesenchymal stem cell group was greater than that in the saline group, while glial fibrillary acidic protein and ionized calcium binding adaptor molecule 1 expression levels decreased. (5) Human umbilical cord mesenchymal stem cell treatment increased the number of CD31\n                    <jats:sup>+<\/jats:sup>\n                    microvessels and doublecortin-positive cells after ischemic stroke. Human umbilical cord mesenchymal stem cells also upregulated the expression of CD31\n                    <jats:sup>+<\/jats:sup>\n                    \/Ki67\n                    <jats:sup>+<\/jats:sup>\n                    . (6) At 14 days after intrathecal administration, brain-derived neurotrophic factor expression in the peri-infarct area and the concentrations of brain-derived neurotrophic factor in the cerebrospinal fluid in both human umbilical cord mesenchymal stem cell groups were significantly greater than those in the saline group and persisted until the 28\n                    <jats:sup>th<\/jats:sup>\n                    day. Taken together, these results indicate that the intrathecal administration of human umbilical cord mesenchymal stem cells via cerebellomedullary cistern injection is safe and effective for the treatment of ischemic stroke in rats. The mechanisms may include alleviating the local inflammatory response in the peri-infarct region, promoting neurogenesis and angiogenesis, and enhancing the production of neurotrophic factors.\n                  <\/jats:p>","DOI":"10.4103\/nrr.nrr-d-24-00683","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:37:28Z","timestamp":1731479848000},"page":"1172-1182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Preclinical safety and ef\ufb01cacy evaluation of the intrathecal transplantation of GMP-grade human umbilical cord mesenchymal stem cells for ischemic stroke"],"prefix":"10.4103","volume":"21","author":[{"given":"Zejia","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaohua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd., Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejia","family":"Li","sequence":"additional","affiliation":[{"name":"Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd., Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermei","family":"Luo","sequence":"additional","affiliation":[{"name":"Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd., Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5631-9713","authenticated-orcid":false,"given":"Haijia","family":"Chen","sequence":"additional","affiliation":[{"name":"Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd., Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-369X","authenticated-orcid":false,"given":"Yidong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China"},{"name":"Guangdong Province Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China"},{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12035-018-1067-z","article-title":"Therapeutic potential of a combination of electroacupuncture and TrkB-expressing mesenchymal stem cells for ischemic stroke","volume":"56","author":"Ahn","year":"2019","journal-title":"Mol Neurobiol"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.omtm.2023.07.005","article-title":"iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress","volume":"30","author":"Arakawa","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nm747","article-title":"Neuronal replacement from endogenous precursors in the adult brain after stroke","volume":"8","author":"Arvidsson","year":"2002","journal-title":"Nat Med"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"111709","DOI":"10.1016\/j.biopha.2021.111709","article-title":"Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model","volume":"140","author":"Asgari Taei","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/cns.13886","article-title":"Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke","volume":"28","author":"Asgari Taei","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"9636897211034464","DOI":"10.1177\/09636897211034464","article-title":"Intrathecal transplantation of autologous and allogeneic bone marrow-derived mesenchymal stem cells in dogs","volume":"30","author":"Benavides","year":"2021","journal-title":"Cell Transplant"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/acn3.51972","article-title":"In vivo detection of poststroke cerebral cell proliferation in rodents and humans","volume":"11","author":"Chiang","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41401-023-01061-2","article-title":"Angiogenesis after ischemic stroke","volume":"44","author":"Fang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"9923566","DOI":"10.1155\/2021\/9923566","article-title":"Progress in mesenchymal stem cell therapy for ischemic stroke","volume":"2021","author":"Guo","year":"2021","journal-title":"Stem Cells Int"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/sctm.17-0260","article-title":"Embryonic stem cell-derived mesenchymal stem cells (MSCs) have a superior neuroprotective capacity over fetal MSCs in the hypoxic-ischemic mouse brain","volume":"7","author":"Hawkins","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.WCB.0000041283.53351.CB","article-title":"Temporal profile of angiogenesis and expression of related genes in the brain after ischemia","volume":"23","author":"Hayashi","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"R13-20260422","first-page":"910","article-title":"Crosstalk of astrocytes and other cells during ischemic stroke","volume":"12","author":"He","year":"2022","journal-title":"Life (Basel)"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","article-title":"Management of acute ischemic stroke","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit Care Med"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10072-023-07032-z","article-title":"A review and meta-analysis of stem cell therapies in stroke patients: effectiveness and safety evaluation","volume":"45","author":"Hovhannisyan","year":"2024","journal-title":"Neurol Sci"},{"key":"R16-20260422","first-page":"497","article-title":"Comparsion between intravenous delivered human fetal bone marrow mesenchymal stromal cells and mononuclear cells in the treatment of rat cerebral infarct","volume":"38","author":"Huang","year":"2016","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/STROKEAHA.112.677328","article-title":"Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke","volume":"44","author":"Ishizaka","year":"2013","journal-title":"Stroke"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"129145","DOI":"10.1155\/2014\/129145","article-title":"Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model","volume":"2014","author":"Jeong","year":"2014","journal-title":"Biomed Res Int"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1073\/pnas.1000154107","article-title":"Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/cns.13947","article-title":"Transplantation of modified human bone marrow-derived stromal cells affords therapeutic effects on cerebral ischemia in rats","volume":"28","author":"Kawauchi","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/ijms21041272","article-title":"Intrathecal injection in a rat model: a potential route to deliver human Wharton\u2019s jelly-derived mesenchymal stem cells into the brain","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neures.2009.06.004","article-title":"Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update","volume":"65","author":"Lessmann","year":"2009","journal-title":"Neurosci Res"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1159\/000489384","article-title":"Intravenously delivered allogeneic mesenchymal stem cells bidirectionally regulate inflammation and induce neurotrophic effects in distal middle cerebral artery occlusion rats within the first 7 days after stroke","volume":"46","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"111021","DOI":"10.1016\/j.biopha.2020.111021","article-title":"Protection against acute cerebral ischemia\/reperfusion injury by Leonuri Herba Total Alkali via modulation of BDNF-TrKB-PI3K\/Akt signaling pathway in rats","volume":"133","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2147\/IJN.S444009","article-title":"Extracellular vesicles maintain blood-brain barrier integrity by the suppression of Caveolin-1\/CD147\/VEGFR2\/MMP pathway after ischemic stroke","volume":"19","author":"Li","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/scrt79","article-title":"Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia","volume":"2","author":"Lim","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","article-title":"Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation","volume":"56","author":"Lima Giacobbo","year":"2019","journal-title":"Mol Neurobiol"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"114726","DOI":"10.1016\/j.expneurol.2024.114726","article-title":"BMSC-Exosomes attenuate ALP dysfunction by restoring lysosomal function via the mTOR\/TFEB Axis to reduce cerebral ischemia-reperfusion injury","volume":"376","author":"Liu","year":"2024","journal-title":"Exp Neurol"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"R30-20260422","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.stemcr.2021.05.012","article-title":"ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update","volume":"16","author":"Lovell-Badge","year":"2021","journal-title":"Stem Cell Reports"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4103\/1673-5374.389303","article-title":"High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke","volume":"19","author":"Luo","year":"2024","journal-title":"Neural Regen Res"},{"key":"R32-20260422","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnmol.2017.00080","article-title":"Hif-1\u03b1 overexpression improves transplanted bone mesenchymal stem cells survival in rat MCAO stroke model","volume":"10","author":"Lv","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"R33-20260422","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12917-015-0361-5","article-title":"Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses","volume":"11","author":"Maia","year":"2015","journal-title":"BMC Vet Res"},{"key":"R34-20260422","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcdb.2018.12.003","article-title":"The role of neurogenesis in neurorepair after ischemic stroke","volume":"95","author":"Marques","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"R35-20260422","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12975-018-0610-6","article-title":"Delayed recanalization promotes functional recovery in rats following permanent middle cerebral artery occlusion","volume":"9","author":"McBride","year":"2018","journal-title":"Transl Stroke Res"},{"key":"R36-20260422","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4103\/1673-5374.382227","article-title":"Autophagy in neural stem cells and glia for brain health and diseases","volume":"19","author":"Nagayach","year":"2024","journal-title":"Neural Regen Res"},{"key":"R37-20260422","doi-asserted-by":"crossref","first-page":"641970","DOI":"10.3389\/fnins.2021.641970","article-title":"Intra-arterial stem cell transplantation in experimental stroke in rats: real-time MR visualization of transplanted cells starting with their first pass through the brain with regard to the therapeutic action","volume":"15","author":"Namestnikova","year":"2021","journal-title":"Front Neurosci"},{"key":"R38-20260422","first-page":"1","article-title":"Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction","author":"Namioka","year":"2018","journal-title":"J Neurosurg"},{"key":"R39-20260422","doi-asserted-by":"crossref","first-page":"546659","DOI":"10.3389\/fncel.2020.546659","article-title":"Intracerebral transplants of GMP-grade human umbilical cord-derived mesenchymal stromal cells effectively treat subacute-phase ischemic stroke in a rodent model","volume":"14","author":"Noh","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R40-20260422","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jcyt.2015.04.007","article-title":"Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells","volume":"17","author":"Oh","year":"2015","journal-title":"Cytotherapy"},{"key":"R41-20260422","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/14653249.2010.487899","article-title":"Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury","volume":"12","author":"Pal","year":"2010","journal-title":"Cytotherapy"},{"key":"R42-20260422","doi-asserted-by":"crossref","first-page":"1305087","DOI":"10.3389\/fimmu.2024.1305087","article-title":"The ins and outs of microglial cells in brain health and disease","volume":"15","author":"Pallar\u00e9s-Moratalla","year":"2024","journal-title":"Front Immunol"},{"key":"R43-20260422","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/DDDT.S460998","article-title":"Revolutionizing stroke recovery: unveiling the promise of stem cell therapy","volume":"18","author":"Panos","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"R44-20260422","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/ijms22084280","article-title":"Astrocyte activation in neurovascular damage and repair following ischaemic stroke","volume":"22","author":"Patabendige","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R45-20260422","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s12264-019-00388-3","article-title":"Dual functions of microglia in ischemic stroke","volume":"35","author":"Qin","year":"2019","journal-title":"Neurosci Bull"},{"key":"R46-20260422","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R47-20260422","doi-asserted-by":"crossref","first-page":"1332751","DOI":"10.3389\/fnins.2023.1332751","article-title":"Deciphering the impact of cerebrospinal fluid on stem cell fate as a new mechanism to enhance clinical therapy development","volume":"17","author":"Radoszkiewicz","year":"2023","journal-title":"Front Neurosci"},{"key":"R48-20260422","first-page":"147","article-title":"Stem cell transplantation therapy and neurological disorders: current status and future perspectives","volume":"11","author":"Rahman","year":"2022","journal-title":"Biology (Basel)"},{"key":"R49-20260422","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s11064-024-04175-z","article-title":"Role of brain derived neurotrophic factor and related therapeutic strategies in central post-stroke pain","volume":"49","author":"Rajamanickam","year":"2024","journal-title":"Neurochem Res"},{"key":"R50-20260422","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-018-0807-3","article-title":"Cerebrospinal fluid-stem cell interactions may pave the path for cell-based therapy in neurological diseases","volume":"9","author":"Ren","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"R51-20260422","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1179\/1743132812Y.0000000152","article-title":"Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats","volume":"35","author":"Ruan","year":"2013","journal-title":"Neurol Res"},{"key":"R52-20260422","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.nbd.2010.12.009","article-title":"Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5","volume":"41","author":"Sheikh","year":"2011","journal-title":"Neurobiol Dis"},{"key":"R53-20260422","doi-asserted-by":"crossref","first-page":"1095469","DOI":"10.3389\/fimmu.2022.1095469","article-title":"Pre-clinical efficacy evaluation of human umbilical cord mesenchymal stem cells for ischemic stroke","volume":"13","author":"Shen","year":"2022","journal-title":"Front Immunol"},{"key":"R54-20260422","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymthe.2017.09.026","article-title":"Mesenchymal stromal cells inhibit inflammatory lymphangiogenesis in the cornea by suppressing macrophage in a TSG-6-dependent manner","volume":"26","author":"Song","year":"2018","journal-title":"Mol Ther"},{"key":"R55-20260422","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00281-022-00969-x","article-title":"Sex differences in the inflammatory response to stroke","volume":"45","author":"Tariq","year":"2023","journal-title":"Semin Immunopathol"},{"key":"R56-20260422","doi-asserted-by":"crossref","first-page":"38308","DOI":"10.1038\/srep38308","article-title":"Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE(2)-dependent mechanism","volume":"6","author":"Vasandan","year":"2016","journal-title":"Sci Rep"},{"key":"R57-20260422","doi-asserted-by":"crossref","first-page":"105605","DOI":"10.1016\/j.neuint.2023.105605","article-title":"HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke","volume":"170","author":"Vatte","year":"2023","journal-title":"Neurochem Int"},{"key":"R58-20260422","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.4103\/1673-5374.391313","article-title":"Emerging strategies for nerve repair and regeneration in ischemic stroke: neural stem cell therapy","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R59-20260422","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.4103\/1673-5374.390959","article-title":"The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R60-20260422","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/thno.69217","article-title":"Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke","volume":"12","author":"Xu","year":"2022","journal-title":"Theranostics"},{"key":"R61-20260422","doi-asserted-by":"crossref","first-page":"114619","DOI":"10.1016\/j.expneurol.2023.114619","article-title":"Bone marrow mesenchymal stem cells therapy regulates sphingolipid and glycerophospholipid metabolism to promote neurological recovery in stroke rats: A metabolomics analysis","volume":"372","author":"Xu","year":"2024","journal-title":"Exp Neurol"},{"key":"R62-20260422","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cells13020112","article-title":"The role of stem cells as therapeutics for ischaemic stroke","volume":"13","author":"Ya","year":"2024","journal-title":"Cells"},{"key":"R63-20260422","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0271678X17731964","article-title":"Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke","volume":"38","author":"Yamaguchi","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"R64-20260422","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s12967-024-05222-7","article-title":"Meldonium, as a potential neuroprotective agent, promotes neuronal survival by protecting mitochondria in cerebral ischemia-reperfusion injury","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"key":"R65-20260422","doi-asserted-by":"crossref","first-page":"112184","DOI":"10.1016\/j.yexcr.2020.112184","article-title":"Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study","volume":"395","author":"Yang","year":"2020","journal-title":"Exp Cell Res"},{"key":"R66-20260422","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3390\/cells10112997","article-title":"Cell therapy of stroke: do the intra-arterially transplanted mesenchymal stem cells cross the blood-brain barrier?","volume":"10","author":"Yarygin","year":"2021","journal-title":"Cells"},{"key":"R67-20260422","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3727\/096368916X693536","article-title":"Bone marrow stromal cells combined with sodium ferulate and n-butylidenephthalide promote the effect of therapeutic angiogenesis via advancing astrocyte-derived trophic factors after ischemic stroke","volume":"26","author":"Zhang","year":"2017","journal-title":"Cell Transplant"},{"key":"R68-20260422","doi-asserted-by":"crossref","first-page":"8536785","DOI":"10.1155\/2019\/8536785","article-title":"Autologous mesenchymal stem cell transplantation in multiple sclerosis: a meta-analysis","volume":"2019","author":"Zhou","year":"2019","journal-title":"Stem Cells Int"},{"key":"R69-20260422","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/scd.2014.0076","article-title":"Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1","volume":"24","author":"Zhu","year":"2015","journal-title":"Stem Cells Dev"},{"key":"R70-20260422","doi-asserted-by":"crossref","first-page":"615998","DOI":"10.3389\/fphar.2021.615998","article-title":"Notoginsenoside R1 improves cerebral ischemia\/reperfusion injury by promoting neurogenesis via the BDNF\/Akt\/CREB pathway","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R71-20260422","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4103\/1673-5374.346466","article-title":"Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke","volume":"18","author":"Zhu","year":"2023","journal-title":"Neural Regen Res"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:11Z","timestamp":1786647311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-24-00683","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"2024-06-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}